RPRX · CIK 0001802768 · FY2025 live · 2025-12-31
Royalty Pharma plc
View as
Model
Classic Z
FY2025
1.19
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
58
0–100 · Classic Z tape · not a PD
Book standing
49
Year change
—
Market PD
—
O-score
82
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
1.19
Z″ 2.25
Score 1.19 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.051.2 × = 0.05X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
0.121.4 × = 0.17X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
0.083.3 × = 0.26X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.980.6 × = 0.59X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.121 × = 0.12
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Royalty Pharma plc is on classic Z at 1.19 (distress) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 69th percentile in Healthcare.
- RLAYDistressRelay Therapeutics, Inc.1.21
- CBIODistressCRESCENT BIOPHARMA, INC.1.22
- ZOMDFDistressZomedica Corp.1.22
- CBLLDistressCeribell, Inc.1.22
- INDVDistressIndivior Pharmaceuticals, Inc.1.16
- KIDSDistressORTHOPEDIATRICS CORP1.23
- DCTHDistressDELCATH SYSTEMS, INC.1.15
- TRDADistressEntrada Therapeutics, Inc.1.15
KPI widgets
Current assets
$1.5B
Total assets
$19.6B
Current liabilities
$636M
Total liabilities
$9.9B
Working capital
$892M
Retained earnings
$2.4B
EBIT
$1.6B
Total sales
$2.4B
Book equity
$9.7B
Accession 0001802768-26-000003. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.